论文部分内容阅读
我们应用氨酰心安治疗急性心肌梗塞(AMI)合并快速房颤17例,疗效满意,现报告如下。 临床资料:本组均符合WHO制订的急性心肌梗塞的诊断标准。病人年龄42～75岁,平均58.5岁。既往均无房颤史。心梗位于前壁11例,下壁4例,高侧壁2例。病程4～36小时,平均20小时。入院时心室率105～130次/min,无心衰、低血压、传导阻滞或哮喘等。 治疗方法:除按AMI给予保护和维持心脏功能,挽救濒死心肌,防止梗塞面积扩大,缩小心肌缺血范围等综合治疗外;口服氨酰心安50mg,每日2～3次,日总量不超过300mg。一旦复律后减量为每日25mg维持。若服药后心率<50次/min,
We use atenolol treatment of acute myocardial infarction (AMI) combined with rapid atrial fibrillation in 17 cases, the results are satisfactory, are as follows. Clinical data: This group are in line with WHO diagnostic criteria for acute myocardial infarction. Patients aged 42 to 75 years old, with an average of 58.5 years old. No previous history of atrial fibrillation. Myocardial infarction in the anterior wall in 11 cases, 4 cases of inferior wall, 2 cases of high side wall. Duration of 4 to 36 hours, an average of 20 hours. Admission ventricular rate of 105 to 130 beats / min, no heart failure, hypotension, block or asthma. Treatment: Except AMI to protect and maintain cardiac function, save the dying myocardium, to prevent the expansion of infarct size, reduce the scope of myocardial ischemia and other comprehensive treatment; oral atenolol 50mg, 2 to 3 times a day, the total daily dose is not Over 300mg. Once cardioversion reduction of 25mg daily maintenance. If the medication after heart rate <50 beats / min,